de Courten B - Search Results

1

Advanced glycation endproducts in food and their effects on health.

Poulsen MW, Hedegaard RV, Andersen JM, de Courten B, Bügel S, Nielsen J, Skibsted LH, Dragsted LO. Poulsen MW, et al. Among authors: de courten b. Food Chem Toxicol. 2013 Oct;60:10-37. doi: 10.1016/j.fct.2013.06.052. Epub 2013 Jul 16. Food Chem Toxicol. 2013. PMID: 23867544 Review.

2

Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women.

Mark AB, Poulsen MW, Andersen S, Andersen JM, Bak MJ, Ritz C, Holst JJ, Nielsen J, de Courten B, Dragsted LO, Bügel SG. Mark AB, et al. Among authors: de courten b. Diabetes Care. 2014;37(1):88-95. doi: 10.2337/dc13-0842. Epub 2013 Aug 19. Diabetes Care. 2014. PMID: 23959566 Clinical Trial.

3

Associations between Urinary Advanced Glycation End Products and Cardiometabolic Parameters in Metabolically Healthy Obese Women.

Baye E, Mark AB, Poulsen MW, Andersen JM, Dragsted LO, Bügel SG, de Courten B. Baye E, et al. Among authors: de courten b. J Clin Med. 2019 Jul 10;8(7):1008. doi: 10.3390/jcm8071008. J Clin Med. 2019. PMID: 31295874 Free PMC article.

4

Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure.

Sourris KC, Lyons JG, Dougherty SL, Chand V, Straznicky NE, Schlaich MP, Grima MT, Cooper ME, Kingwell BA, de Courten MP, Forbes JM, de Courten B. Sourris KC, et al. Among authors: de courten b, de courten mp. Clin Chem Lab Med. 2014 Jan 1;52(1):129-38. doi: 10.1515/cclm-2012-0850. Clin Chem Lab Med. 2014. PMID: 23525877

5

Disparity in the micronutrient content of diets high or low in advanced glycation end products (AGEs) does not explain changes in insulin sensitivity.

Pearce K, Hatzinikolas A, Moran L, de Courten MPJ, Forbes J, Scheijen JLJM, Schalkwijk CG, Walker K, de Courten B. Pearce K, et al. Among authors: de courten mpj, de courten b. Int J Food Sci Nutr. 2017 Dec;68(8):1021-1026. doi: 10.1080/09637486.2017.1319468. Epub 2017 May 2. Int J Food Sci Nutr. 2017. PMID: 28460575 Clinical Trial.

6

Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial.

Baye E, de Courten MP, Walker K, Ranasinha S, Earnest A, Forbes JM, de Courten B. Baye E, et al. Among authors: de courten b, de courten mp. Sci Rep. 2017 Jun 23;7(1):4123. doi: 10.1038/s41598-017-04214-6. Sci Rep. 2017. PMID: 28646140 Free PMC article. Clinical Trial.

7

Targeted reduction of advanced glycation improves renal function in obesity.

Harcourt BE, Sourris KC, Coughlan MT, Walker KZ, Dougherty SL, Andrikopoulos S, Morley AL, Thallas-Bonke V, Chand V, Penfold SA, de Courten MP, Thomas MC, Kingwell BA, Bierhaus A, Cooper ME, de Courten B, Forbes JM. Harcourt BE, et al. Among authors: de courten b, de courten mp. Kidney Int. 2011 Jul;80(2):190-8. doi: 10.1038/ki.2011.57. Epub 2011 Mar 16. Kidney Int. 2011. PMID: 21412218 Free article. Clinical Trial.

8

Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial.

de Courten B, de Courten MP, Soldatos G, Dougherty SL, Straznicky N, Schlaich M, Sourris KC, Chand V, Scheijen JL, Kingwell BA, Cooper ME, Schalkwijk CG, Walker KZ, Forbes JM. de Courten B, et al. Among authors: de courten mp. Am J Clin Nutr. 2016 Jun;103(6):1426-33. doi: 10.3945/ajcn.115.125427. Epub 2016 Mar 30. Am J Clin Nutr. 2016. PMID: 27030534 Free article. Clinical Trial.

9

Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects.

Forbes JM, Sourris KC, de Courten MP, Dougherty SL, Chand V, Lyons JG, Bertovic D, Coughlan MT, Schlaich MP, Soldatos G, Cooper ME, Straznicky NE, Kingwell BA, de Courten B. Forbes JM, et al. Among authors: de courten b, de courten mp. Amino Acids. 2014 Feb;46(2):321-6. doi: 10.1007/s00726-013-1542-9. Epub 2013 Jul 6. Amino Acids. 2014. PMID: 23832534

10

Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes.

Koska J, Saremi A, Howell S, Bahn G, De Courten B, Ginsberg H, Beisswenger PJ, Reaven PD; VADT Investigators. Koska J, et al. Among authors: de courten b. Diabetes Care. 2018 Mar;41(3):570-576. doi: 10.2337/dc17-1740. Epub 2017 Dec 5. Diabetes Care. 2018. PMID: 29208654 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page